Eli Lilly And Company ((LLY)) announced an update on their ongoing clinical study. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst ...

An experimental GLP-1/glucagon (GCP) dual receptor agonist from Eli Lilly and its Chinese partner, Innovent, has bested Novo Nordisk’s reigning GLP-1 semaglutide, in a phase 3 study across both blood ...

Eli Lilly And Company ((LLY)) announced an update on their ongoing clinical study. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst ...

Eli Lilly and Company (NYSE:LLY) is among the 10 Best Money Making Stocks to Invest In. According to a U.S. registry of clinical trials, the firm has halted an experimental drug study designed to stop ...

Sept 25 (Reuters) - Eli Lilly (LLY.N), opens new tab has halted a study of an experimental drug, designed to prevent obesity patients from losing too much muscle, due to strategic business reasons, ...

(RTTNews) - Eli Lilly and Company (LLY) has decided to halt a Phase 2b obesity study, citing strategic business considerations, according to ClinicalTrials.gov. The study was designed to evaluate the ...

On Wednesday, Eli Lilly & Co. (NYSE: LLY) ended a mid-stage study of its experimental drug bimagrumab in obesity patients with type 2 diabetes, just weeks after it began. The company cited strategic ...

Eli Lilly LLY0.96%increase; green up pointing triangle said a third late-stage study of its experimental anti-obesity pill hit its key goals, paving the way for the drugmaker to begin regulatory ...

Eli Lilly said a third late-stage study of its experimental anti-obesity pill hit its key goals, paving the way for the drugmaker to begin regulatory submissions. Eli Lilly on Tuesday said the Phase 3 ...

Eli Lilly is releasing new Phase 3 trial results Tuesday. Drugmaker Eli Lilly says its daily oral GLP-1 pill may help people who have obesity and people with Type 2 diabetes lose approximately 23 ...

Eli Lilly and Company (NYSE:LLY) is one of the Oversold Fundamentally Strong Stocks to Buy Now. On July 30, the company announced results from the long-term extension (LTE) of the Phase 3 ...

The Marlins recalled Soriano from Triple-A Jacksonville on Friday. Soriano has struggled to a 7.97 ERA and 1.77 WHIP in 12 appearances with the big club this season, but he pitched well during his ...